Neurophth Biotechnology Doses First Patient in Phase III Trial for NR082
China-based gene therapy specialist Neurophth Biotechnology Ltd has announced that the first patient has been...
Bio-Thera Solutions Completes Phase I Study for COVID-19 Antibody BAT2022
Guangzhou-based Bio-Thera Solutions (SHA: 688177) has announced the completion of all dosage groups (from 100...
Allergan Aesthetics Opens Shanghai Innovation Center for Medical Aesthetics
Allergan Aesthetics, a division of AbbVie, has officially opened its Shanghai innovation center, marking a...
Biosyngen to Establish Cell Therapy GMP Facility in Singapore
Biosyngen has announced plans to establish a Cell Therapy GMP Facility in Singapore, aimed at...
Luye Pharma Reports Decline in H1 Revenue and Profits Amid Market Challenges
China-based Luye Pharma Group (HKG: 2186) has released its 2022 interim report, recording RMB 2.85...
Parexel Opens Clinical Study Supply Chain Center in Suzhou
US-based contract research organization (CRO) Parexel has announced the opening of its clinical study supply...
Abbisko Therapeutics Doses First Patient in Phase I Study of ABSK043
Shanghai-based biotech Abbisko Therapeutics Co., Ltd (HKG: 2256) has announced that the first patient has...
Arctic Vision Enrolls First Patient in Phase III Study for ARVN002
China-based ophthalmology specialist Arctic Vision has announced the enrollment of the first patient in a...
3D Medicines Partners with Denfo Medical for Cancer Therapy Development
China-based 3D Medicines has entered into a strategic partnership with compatriot firm Denfo Medical Group,...
Simcere Grants Almirall Global Rights to Autoimmune Drug SIM0278
China’s Jiangsu Simcere Pharmaceutical Co., Ltd (HKG: 2096) has entered into a licensing agreement with...
Insight Lifetech Raises Funds for Cardiovascular Solutions Expansion
Insight Lifetech Co., Ltd, a Shenzhen-based provider of cardiovascular precision intervention solutions, has reportedly secured...
Santen Pharmaceutical Launches New Plant Construction in Suzhou
Japan-based Santen Pharmaceutical Co. has launched the construction of a new plant in Suzhou, Jiangsu...
Legend Biotech’s Carvykti Approved in Japan for Relapsed Multiple Myeloma
China-based Legend Biotech Corporation (NASDAQ: LEGN) has announced that Japan’s Ministry of Health, Labour and...
Eureka Biotech Partners with Ucello for Universal CAR-T Cell Therapy Development
Shenzhen Eureka Biotechnology Co., Limited, a China-based biotech firm, has entered into a partnership with...
Merck Sharp & Dohme Partners with Sinopharm for Molnupiravir in China
US-based Merck Sharp & Dohme (MSD, NYSE: MRK) has entered into a cooperation framework agreement...
NMPA Releases 59th Batch of Reference Drugs for Generic Quality Evaluation
The National Medical Products Administration (NMPA) has released the 59th batch of reference drugs for...
SciClone Pharmaceuticals Reports 10.8% Revenue Growth in 2022 Interim Results
SciClone Pharmaceuticals Inc., formerly a US-based and Nasdaq-listed company that became China-based after going private...
Harbour BioMed Doses First Subject in Phase I Study for HBM9378 in China
China-based Harbour BioMed (HKG: 2142) has announced the completion of the first subject dosing in...
MicroPort CardioFlow’s Alwide Plus Balloon Catheter Approved in Colombia
MicroPort CardioFlow Medtech Co., Ltd (HKG: 2160), a spin-off of China-based MicroPort Scientific Corp (HKG:...
Zai Lab Licenses Seagen’s Tivdak for Greater China Development and Commercialization
Chinese firm Zai Lab Ltd (NASDAQ: ZLAB, HKG: 9688) has formed a collaboration with US-based...